Scars Run Deep: Problematic Morphology and Immunoprofile of Scars in Renal Oncocytomas.

immunohistochemistry kidney oncocytoma scar

Journal

International journal of surgical pathology
ISSN: 1940-2465
Titre abrégé: Int J Surg Pathol
Pays: United States
ID NLM: 9314927

Informations de publication

Date de publication:
04 May 2023
Historique:
medline: 5 5 2023
pubmed: 5 5 2023
entrez: 5 5 2023
Statut: aheadofprint

Résumé

In some instances, the central scar of renal oncocytoma can demonstrate entrapped cells with unusual morphology and aberrant immunoprofile creating potential diagnostic confusion. Herein, 100 renal oncocytomas containing scars with embedded epithelial cells were identified from 6 institutions, including nephrectomies (64% partial, 36% radical) of similar laterality (left = 51%) and sex distribution (male = 56%), with patient ages ranging from 38 to 86 years (mean = 64.3years) and tumor sizes ranging from 2 to 16 cm (mean = 5.3 cm). Immunohistochemistry was performed on all tumors for KRT7, KIT, vimentin, and CA9 with staining intensity and extensity separately analyzed. Of 4 architectural patterns of cells within the scar, 60% showed tubular pattern. Of 4 cytologies within the scar, flat/elongated (49%) and cuboidal cells (40%) predominated. Within the scar, 62% showed eosinophilic cytoplasm, with 38% showing both cleared and eosinophilic cytoplasm; notably, 79% showed higher grade nuclei than typical oncocytes. A subset of scar cells showed mucinous-like basophilic secretions (19%). Compared to background renal oncocytoma, tumor cells within the scar were more often positive for vimentin, KRT7, and CA9 and more frequently negativity for KIT. Specifically, of the notable "aberrant" immunoprofiles, 79% showed KRT7 positivity/KIT negativity/vimentin positive, 84% showed vimentin positivity/CA9 positivity, and 78% showed KIT negativity/vimentin positivity/CA9 positivity. While encountering scars within renal oncocytomas is not uncommon, what is not well appreciated is the unique morphology and immunohistochemistry of tumor cells within the scar. Comparing tumor morphology and immunoprofile of the scar to the background oncocytoma is helpful to avoid interpretative confusion.

Identifiants

pubmed: 37143313
doi: 10.1177/10668969231171683
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10668969231171683

Auteurs

Ankur R Sangoi (AR)

Department of Pathology, Stanford Medical Center, Stanford, CA, USA.

Luiz M Nova-Camacho (LM)

Department of Pathology, Donostia University Hospital, San Sebastian, Spain.

Mahmut Akgul (M)

Dpartment of Pathology, Albany Medical Center, Albany, NY, USA.

Francisco J Queipo (FJ)

Department of Pathology, Hospital Universitario de A Coruna, A Coruna, Spain.

Gregorio Aisa (G)

Department of Pathology, Hospital Universitario de Navarra, Pamplona, Spain.

Maria Garcia-Martos (M)

Department of Pathology, Hospital General Universitario Gregorio Maranon, Madrid, Spain.

Angel Panizo (A)

Department of Pathology, Hospital Universitario de Navarra, Pamplona, Spain.

Classifications MeSH